Medical Communications

Showing 15 posts of 6408 posts found.

NHS Trust harnesses AI to speed up treatment

May 22, 2018 Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …
shutterstock_349943306

Clinical trials, Brexit and the question of ‘full alignment’

May 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit, clinical trials, feature, pharma

Gene Matthews, Partner at Leigh Day, reviews the tough decisions the UK has to make regarding its position in the …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
ebola

Ebola threat intensifies in DR Congo

May 18, 2018 Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …

Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy

May 18, 2018 Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …
headache

Amgen/Novartis potential blockbuster migraine med gets FDA nod

May 18, 2018 Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …

Study finds Herceptin use can be halved

May 17, 2018 Medical Communications, Research and Development Herceptin, Roche, biosimilars, biotech, drugs, pharma, pharmaceutical

A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …
ethan__drew_web

Living with an undiagnosed condition

May 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma

Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but …
brexit_flag_0

UK MPs call for Brexit priority over pharma industry

May 17, 2018 Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical

A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …
novartis_side_building

Novartis’ top lawyer retires from role over botched Trump deal

May 16, 2018 Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma

The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …
dialogo

DIA: Pharmacovigilance conference

May 15, 2018 Medical Communications, Research and Development dia

We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …

Bringing the PRO to fruition

May 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
donald_j

Pharma unfazed by Trump price-reduction proposals

May 14, 2018 Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical

President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …
david_horn_solomon

Akari CEO resigns over allegations of spending company funds

May 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …
The Gateway to Local Adoption Series

Latest content